查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1947485

病患登记软体市场：依类型、交付模式、功能、资料库、定价模式和最终用户划分 - 全球预测至 2036 年

Patient Registry Software Market by Type, Delivery, Functionality, Database, Pricing Model, End User - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 262 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球病患登记软体市场预计将以 10.5% 的复合年增长率成长，从 2026 年的 20.4 亿美元成长到 2036 年的约 55.2 亿美元。

本报告对全球五大主要区域的患者登记软体市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至 2036 年的预测。透过广泛的二级和一级研究以及对市场现状的深入分析，我们对关键产业驱动因素、限制因素、机会和挑战进行了影响分析。

推动病患登记软体市场成长的关键因素包括：电子健康记录 (EHR) 的日益普及、提高医疗品质和降低医疗成本的压力不断增加、病患登记资料在上市后监测中的应用日益广泛以及云端解决方案的扩展。 此外，对人口健康管理举措的日益重视、人工智慧与真实世界证据的融合以及以患者为主导的研究网络的发展，预计将为在患者登记软体市场运营的公司创造巨大的增长机会。

市场区隔

目录

第一章：引言

第二章：研究方法

第三章：摘要整理

第四章：市场洞察

  • 市场动态
    • 驱动因素
      • 电子健康记录 (EHR) 的日益普及
      • 提高医疗品质的压力日益增大
      • 上市后监测中病患资料的使用日益增多
      • 人口健康管理计画的扩展
    • 限制因素
      • 资料隐私与安全问题
      • 实施难度高成本
    • 机遇
      • 基于云端的解决方案和以患者为中心的研究网络
      • 真实世界数据 (RWE) 与人工智慧的整合
      • 新兴的个人化医疗应用
      • 罕见疾病登记库的扩展
  • 价值链分析

第五章 全球病患登记软体市场（依登记类型划分）

  • 疾病登记库
    • 慢性病登记库
    • 罕见疾病登记库
    • 肿瘤登记库
  • 药物登记库
    • 上市后监测登记库
    • 药物警戒登记库
  • 医疗器材登记库
    • 植入物註册库
    • 诊断设备註册库
  • 其他註册库类型

第六章：全球病患註册库软体市场（依软体类型划分）

  • 本地部署解决方案
  • 云端解决方案
  • 混合解决方案

第七章：全球病患註册库软体市场（依定价模式划分）

  • 订阅定价
  • 永久许可
  • 以使用量定价
  • 混合定价模式

第八章：全球病患註册库软体市场（依资料库类型划分）

  • 公共註册库
  • 商业註册库
  • 学术和机构註册库

章节第九章：全球病患登记软体市场依功能划分

  • 人群健康管理 (PHM)
  • 健康资讯交换 (HIE) 整合
  • 床边临床决策支援 (POC)
  • 调查与真实世界证据分析
  • 报告和监管合规

第十章：全球病患登记软体市场依最终使用者划分

  • 医院和医疗机构
  • 製药公司
  • 医疗器材製造商
  • 研究机构
  • 政府机构
  • 其他最终用户

第十一章：全球病患登记软体市场依地区划分

  • 北美
    • 美国美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第十二章 竞争格局

  • 主要成长策略
  • 竞争标竿分析
  • 市占率分析

第11章 企业简介

  • SPX FLOW, Inc.
  • EIRICH Machines GmbH
  • Silverson Machines Ltd.
  • Hosokawa Micron B.V.
  • GMM Pfaudler Ltd.
  • Charles Ross &Son Company
  • Readco Kurimoto, LLC
  • Marion Process Solutions
  • Palamatic Process Inc.
  • EKATO Holding GmbH
  • NETZSCH Group
  • Bachiller Group
  • INOXPA S.A.U.
  • MixMor(NOV Inc.)
  • Others

第12章 附录

简介目录
Product Code: MRHC - 10413

Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2036

According to the research report titled, 'Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2036,' the global patient registry software market is expected to reach approximately USD 5.52 billion by 2036 from USD 2.04 billion in 2026, at a CAGR of 10.5% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global patient registry software market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the patient registry software market include the increasing adoption of electronic health records (EHRs), rising pressure to improve quality of care and reduce healthcare costs, growing use of patient registry data for post-marketing surveillance, and expansion of cloud-based solutions. Additionally, the growing emphasis on population health management initiatives, integration of artificial intelligence and real-world evidence, and development of patient-powered research networks are expected to create significant growth opportunities for players operating in the patient registry software market.

Market Segmentation

The patient registry software market is segmented by type (diabetes, cancer, rare diseases, CVD, orthopedic, drugs, device), delivery model (on-premise, cloud), functionality (population health management, health information exchange, point of care, research), database type (public, commercial), pricing model, end-user (hospitals, medical practices, pharmaceutical companies, medical device manufacturers), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Registry Type

By registry type, disease registries dominate the market, accounting for the largest revenue share in 2026. Disease registries are driven by the increasing prevalence of chronic diseases and the growing need for data to support clinical research and public health initiatives. The development of new and advanced disease registries for conditions including cardiovascular diseases, diabetes, cancer, and rare diseases has accelerated market adoption. Disease registries enable healthcare organizations to track patient outcomes, monitor treatment effectiveness, and identify best practices for disease management. Drug and device registries represent the fastest-growing registry type segments, driven by the proliferation of new pharmaceutical products and medical devices, regulatory requirements for post-market surveillance, and expansion of real-world evidence initiatives.

Based on Delivery Model

By delivery model, cloud-based solutions are projected to witness the fastest growth among software types through 2036. Cloud-based platforms offer greater flexibility, scalability, and accessibility compared to on-premise solutions, enabling healthcare organizations to reduce infrastructure costs while improving data accessibility across multiple locations. The emergence of patient-powered research networks (PPRNs) is driving significant innovation in cloud-based solutions. On-premise solutions continue to serve healthcare organizations with specific data security and regulatory compliance requirements, maintaining a significant market share.

Based on Functionality

By functionality, population health management is expected to be the largest functionality segment in 2026. Population health management capabilities enable healthcare organizations to monitor and improve health outcomes across patient populations. Health information exchange (HIE) functionality facilitates seamless data sharing across healthcare systems. Point of care (POC) functionality supports clinical decision-making at the patient encounter level. Research functionality enables clinical research and epidemiological studies, with growing emphasis on real-world evidence collection and analysis.

Based on End-User

By end-user, hospitals and medical practices are projected to be the dominant end-user segment in 2026, driven by the increasing adoption of EHRs and growing emphasis on quality improvement initiatives. Healthcare organizations are utilizing patient registry software to track patient outcomes, monitor treatment effectiveness, and support clinical decision-making. Pharmaceutical and medical device manufacturers are expanding their use of patient registry software for post-marketing surveillance, real-world evidence collection, and regulatory compliance. The increasing regulatory requirements for post-market surveillance are driving adoption of specialized registry solutions among pharmaceutical and device companies.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to hold the largest market share in 2026, driven by advanced healthcare infrastructure, high adoption of EHRs, and strong regulatory framework for data management. Europe and Asia-Pacific are projected to experience steady growth from 2026 to 2036, driven by adoption of advanced healthcare technologies and increasing focus on population health management. Latin America and the Middle East & Africa are emerging markets with growing demand for patient registry software.

Key Players

The key players operating in the global patient registry software market are Phytel, Inc. (IBM Corporation), Quintiles IMS Holdings, Inc., McKesson Corporation, Medidata Solutions, Veradigm LLC, Inovalon Holdings, Inc., Health Catalyst, Inc., Optum, Inc., Allscripts Healthcare Solutions, and Cerner Corporation, among others.

Key Questions Answered in the Report

  • What is the current revenue generated by the patient registry software market globally?
  • At what rate is the global patient registry software market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global patient registry software market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of registry type, delivery model, functionality, and end-user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global patient registry software market?
  • Who are the major players in the global patient registry software market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global patient registry software market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Patient Registry Software Market Assessment -- by Registry Type

  • Diabetes
  • Cancer
  • Rare Diseases
  • Cardiovascular Diseases (CVD)
  • Orthopedic
  • Drug Registries
  • Device Registries

Patient Registry Software Market Assessment -- by Delivery Model

  • On-Premise
  • Cloud-Based

Patient Registry Software Market Assessment -- by Functionality

  • Population Health Management (PHM)
  • Health Information Exchange (HIE)
  • Point of Care (POC)
  • Research

Patient Registry Software Market Assessment -- by Database Type

  • Public
  • Commercial

Patient Registry Software Market Assessment -- by End-User

  • Hospitals and Medical Practices
  • Pharmaceutical Manufacturers
  • Medical Device Manufacturers
  • Healthcare Payers
  • Government and Public Health Agencies

Patient Registry Software Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1 Market Definition
  • 1.2 Market Ecosystem
  • 1.3 Currency & Limitations
    • 1.3.1 Currency
    • 1.3.2 Limitations
  • 1.4 Key Stakeholders

2. Research Methodology

  • 2.1 Research Process
  • 2.2 Data Collection & Validation
    • 2.2.1 Secondary Research
    • 2.2.2 Primary Research
  • 2.3 Market Assessment
    • 2.3.1 Market Size Estimation
    • 2.3.2 Bottom-Up Approach
    • 2.3.3 Top-Down Approach
    • 2.3.4 Growth Forecast
  • 2.4 Assumptions for the Study
  • 2.5 Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1 Introduction
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
      • 4.2.1.1 Rising Adoption of Electronic Health Records (EHRs)
      • 4.2.1.2 Increasing Pressure to Improve Quality of Care
      • 4.2.1.3 Growing Use of Patient Data for Post-Marketing Surveillance
      • 4.2.1.4 Expansion of Population Health Management Programs
    • 4.2.2 Restraints
      • 4.2.2.1 Data Privacy and Security Concerns
      • 4.2.2.2 High Implementation Costs
    • 4.2.3 Opportunities
      • 4.2.3.1 Cloud-Based Solutions and Patient-Powered Research Networks
      • 4.2.3.2 Integration of Real-World Evidence (RWE) and AI
      • 4.2.3.3 Emerging Personalized Medicine Applications
      • 4.2.3.4 Expansion of Rare Disease Registries
  • 4.3 Value Chain Analysis

5. Global Patient Registry Software Market, by Registry Type

  • 5.1 Introduction
  • 5.2 Disease Registries
    • 5.2.1 Chronic Disease Registries
    • 5.2.2 Rare Disease Registries
    • 5.2.3 Oncology Registries
  • 5.3 Drug Registries
    • 5.3.1 Post-Marketing Surveillance Registries
    • 5.3.2 Pharmacovigilance Registries
  • 5.4 Device Registries
    • 5.4.1 Implant Registries
    • 5.4.2 Diagnostic Device Registries
  • 5.5 Other Registry Types

6. Global Patient Registry Software Market, by Software Type

  • 6.1 Introduction
  • 6.2 On-Premise Solutions
  • 6.3 Cloud-Based Solutions
  • 6.4 Hybrid Solutions

7. Global Patient Registry Software Market, by Pricing Model

  • 7.1 Introduction
  • 7.2 Subscription-Based Pricing
  • 7.3 Perpetual License
  • 7.4 Usage-Based Pricing
  • 7.5 Hybrid Pricing Model

8. Global Patient Registry Software Market, by Database Type

  • 8.1 Introduction
  • 8.2 Public Registries
  • 8.3 Commercial Registries
  • 8.4 Academic & Institutional Registries

9. Global Patient Registry Software Market, by Functionality

  • 9.1 Introduction
  • 9.2 Population Health Management (PHM)
  • 9.3 Health Information Exchange (HIE) Integration
  • 9.4 Point-of-Care (POC) Clinical Decision Support
  • 9.5 Research & Real-World Evidence Analytics
  • 9.6 Reporting & Regulatory Compliance

10. Global Patient Registry Software Market, by End User

  • 10.1 Introduction
  • 10.2 Hospitals and Medical Practices
  • 10.3 Pharmaceutical Companies
  • 10.4 Medical Device Manufacturers
  • 10.5 Research Institutions
  • 10.6 Government Agencies
  • 10.7 Other End Users

11. Global Patient Registry Software Market, by Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Russia
    • 11.3.7 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Australia
    • 11.4.6 Rest of Asia-Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 Rest of Middle East & Africa

12. Competitive Landscape

  • 12.1 Introduction
  • 12.2 Key Growth Strategies
  • 12.3 Competitive Benchmarking
  • 12.4 Market Share Analysis

13. Company Profiles

  • 13.1 Phytel, Inc. (IBM Corporation)
  • 13.2 IQVIA Holdings Inc.
  • 13.3 McKesson Corporation
  • 13.4 Medidata Solutions
  • 13.5 Veradigm LLC
  • 13.6 Inovalon Holdings, Inc.
  • 13.7 Health Catalyst, Inc.
  • 13.8 Optum, Inc.
  • 13.9 Allscripts Healthcare Solutions
  • 13.10 Oracle Cerner
  • 13.11 Others

14. Appendix

  • 14.1 Questionnaire
  • 14.2 Available Customization